<table id="id_ee01db57-6f55-43cf-a0e4-bde49fe6588e" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<thead>
<tr id="id_ea5bc3e2-3009-44eb-a3a6-fecb4b84af32" stylecode="Toprule">
<td align="center" colspan="3" stylecode="Botrule" valign="top">
<content stylecode="bold">Table 7. Erosive Esophagitis Patient Healing Rates </content>
</td>
</tr>
<tr id="id_8edeb8e0-cfbf-4424-bb85-dc9032d85775">
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="center" colspan="2" stylecode="Botrule" valign="top"> Healed / Evaluable </td>
</tr>
<tr id="id_7de47893-fb7d-469f-a04b-a44dde2c130e" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="center" stylecode="Rrule" valign="top"> Placebo* <br/>n=229 </td>
<td align="center" valign="top"> Ranitidine Tablets, USP<br/>150 mg q.i.d.*<br/>n=215 </td>
</tr>
</thead>
<tbody>
<tr id="id_c4c0e39f-201e-4521-b9bd-abd6afee166e" stylecode="Toprule">
<td align="left" stylecode="Botrule Toprule Rrule" valign="top">Week 4</td>
<td align="center" stylecode="Botrule Rrule" valign="top">43/198 (22%)</td>
<td align="center" stylecode="Botrule" valign="top">96/206 (47%) <sup>†</sup>
</td>
</tr>
<tr id="id_06b89e7f-f953-4643-95f1-8ad43f9dc371">
<td align="left" stylecode="Botrule Rrule" valign="top">Week 8</td>
<td align="center" stylecode="Botrule Rrule" valign="top">63/176 (36%)</td>
<td align="center" stylecode="Botrule" valign="top">142/200 (71%) <sup>†</sup>
</td>
</tr>
<tr id="id_5e3a3105-c7a0-446e-9202-f923f10f96c6" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="top">Week 12</td>
<td align="center" stylecode="Rrule" valign="top">92/159 (58%)</td>
<td align="center" valign="top">162/192 (84%) <sup>†</sup>
</td>
</tr>
</tbody>
</table>